Abstract
Five patients with primary biliary cirrhosis and prolonged cholestasis underwent intensive plasmapheresis. The indications for plasmapheresis included intractable pruritus or hypercholesterolemia and xanthomatous neuropathy. Patients noted a rapid improvement of pruritus and fatigue which was sustained as long as plasmapheresis was continued. Cholesterol levels were lowered an average of 10.3 mmol/l and xanthomata were reduced in three of four patients. Two patients with painful neuropathy caused by xanthomata experienced relief of this symptom. The liver and spleen size were not affected by plasmapheresis, and activities of aminotransferases, alkaline phosphatase and titres of mitochondrial antibody remained unchanged. We conclude that plasmapheresis has a role in the therapeutic management of patients with advanced primary biliary cirrhosis who are disabled by the complications of pruritus, xanthomatous neuropathy, or hypercholesterolemia with xanthoma formation.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Clarke A. K., Galbraith R. M., Hamilton E. B., Williams R. Rheumatic disorders in primary biliary cirrhosis. Ann Rheum Dis. 1978 Feb;37(1):42–47. doi: 10.1136/ard.37.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eriksson S., Lindgren S. Plasma exchange in primary biliary cirrhosis. N Engl J Med. 1980 Apr 3;302(14):809–809. doi: 10.1056/NEJM198004033021415. [DOI] [PubMed] [Google Scholar]
- Keeling P. W., Bull J., Kingston P., Thompson R. P. Plasma exchange in primary biliary cirrhosis. Postgrad Med J. 1981 Jul;57(669):433–435. doi: 10.1136/pgmj.57.669.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lauterburg B. H., Taswell H. F., Pineda A. A., Dickson E. R., Burgstaler E. A., Carlson G. L. Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads. Lancet. 1980 Jul 12;2(8185):53–55. doi: 10.1016/s0140-6736(80)92938-4. [DOI] [PubMed] [Google Scholar]
- Rubenstein M. D., Wall R. T., Wood G. S., Edwards M. A. Complications of therapeutic apheresis, including a fatal case with pulmonary vascular occlusion. Am J Med. 1983 Jul;75(1):171–174. doi: 10.1016/0002-9343(83)91184-1. [DOI] [PubMed] [Google Scholar]
- SCHAFFNER F., KLION F. M., LATUFF A. J. THE LONG TERM USE OF CHOLESTYRAMINE IN THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS. Gastroenterology. 1965 Mar;48:293–298. [PubMed] [Google Scholar]
- Schaffner F., Popper H. Clinical-pathologic relations in primary biliary cirrhosis. Prog Liver Dis. 1982;7:529–554. [PubMed] [Google Scholar]
- Shapiro J. M., Smith H., Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut. 1979 Feb;20(2):137–140. doi: 10.1136/gut.20.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thomas H. C., Potter B. J., Sherlock S. Is primary biliary cirrhosis an immune complex disease? Lancet. 1977 Dec 17;2(8051):1261–1263. doi: 10.1016/s0140-6736(77)92666-6. [DOI] [PubMed] [Google Scholar]
- Thomas P. K., Walker J. G. Xanthomatous neuropathy in primary biliary cirrhosis. Brain. 1965 Dec;88(5):1079–1088. doi: 10.1093/brain/88.5.1079. [DOI] [PubMed] [Google Scholar]
- Thompson G. R. Plasma exchange for hypercholesterolaemia. Lancet. 1981 Jun 6;1(8232):1246–1248. doi: 10.1016/s0140-6736(81)92412-0. [DOI] [PubMed] [Google Scholar]
- Turnberg L. A., Mahoney M. P., Gleeson M. H., Freeman C. B., Gowenlock A. H. Plasmaphoresis and plasma exchange in the treatment of hyperlipaemia and xanthomatous neuropathy in patients with primary biliary cirrhosis. Gut. 1972 Dec;13(12):976–981. doi: 10.1136/gut.13.12.976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wands J. R., Dienstag J. L., Bhan A. K., Feller E. R., Isselbacher K. J. Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med. 1978 Feb 2;298(5):233–237. doi: 10.1056/NEJM197802022980502. [DOI] [PubMed] [Google Scholar]